Dorin Toader
0000-0001-6330-5280
Mersana Therapeutics Inc
5 papers found
Refreshing results…
Data from Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer
Supplementary Data from Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer
Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase Inhibitors
The Development and Scale-Up of an Antibody Drug Conjugate Tubulysin Payload
Missing publications? Search for publications with a matching author name.